Directors' Options
2007年4月4日 - 10:13PM
RNSを含む英国規制内ニュース (英語)
RNS Number:4305U
Henderson Morley PLC
04 April 2007
FOR IMMEDIATE RELEASE 04 APRIL 2007
HENDERSON MORLEY PLC
(AIM)
Business: Drug Discovery
DIRECTORS' OPTIONS
The Board of Henderson Morley plc, the AIM listed drug discovery company,
announces today that it has granted options over 2,500,000 Ordinary Shares at an
exercise price of 2.25p to Chairman Andrew Knight, options over 2,500,000
Ordinary Shares at an exercise price of 2.25p to Chief Executive Dr Ian Pardoe
and options over 800,000 Ordinary Shares at an exercise price of 2.25p to
Finance Director Christopher Pate. These options are exercisable for a period of
five years from 1 May 2007.
--ENDS--
Enquiries:
HENDERSON MORLEY PLC Tel: 0121 442 4600
Andrew Knight, Chairman
BISHOPSGATE COMMUNICATIONS LTD Tel: 020 7562 3350
Maxine Barnes
Nick Rome
BREWIN DOLPHIN SECURITIES LTD Tel: 0113 241 0126
Neil Baldwin
Further information on Henderson Morley plc can be accessed through the
Company's website at www.henderson-morley.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUUUBUCUPMGWC
Henderson Mrly. (LSE:HML)
過去 株価チャート
から 7 2024 まで 8 2024
Henderson Mrly. (LSE:HML)
過去 株価チャート
から 8 2023 まで 8 2024
Real-Time news about Henderson Mrly. (ロンドン証券取引所): 0 recent articles
その他のHenderson Morley Plcニュース記事